Advanced search
Publication Cover
Expert Review of Clinical Pharmacology Volume 4, 2011 - Issue 5
Submit an article Journal homepage
364
Views
89
CrossRef citations to date
0
Altmetric
Review

Innovative clinical trial design for pediatric therapeutics

Matthew M Laughon School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
,
Daniel K Benjamin Department of Pediatrics, Duke University, Durham, NC, USA; Duke Clinical Research Institute, Durham, NC, USA;[email protected]
,
Edmund V Capparelli University of California at San Diego, San Diego, CA, USA; University of California at San Diego, San Diego, CA, USA
,
Gregory L Kearns The Children’s Mercy Hospital, Kansas City, MO, USA; The Children’s Mercy Hospital, Kansas City, MO, USA
,
Katherine Berezny Duke Clinical Research Institute, Durham, NC, USA; Duke Clinical Research Institute, Durham, NC, USA
,
Ian M Paul Penn State College of Medicine, Hershey, PA, USA; Penn State College of Medicine, Hershey, PA, USA
,
Kelly Wade Department of Pediatrics, University of Pennsylvania, Philadelphia, PA, USA; Department of Pediatrics, University of Pennsylvania, Philadelphia, PA, USA
,
Jeff Barrett Penn State College of Medicine, Hershey, PA, USA; Penn State College of Medicine, Hershey, PA, USA
,
Phillip Brian Smith Department of Pediatrics, Duke University, Durham, NC, USA; Duke Clinical Research Institute, Durham, NC, USA; Department of Pediatrics, Duke University, Durham, NC, USA; Duke Clinical Research Institute, Durham, NC, USA
&
Michael Cohen-Wolkowiez Department of Pediatrics, Duke University, Durham, NC, USA; Duke Clinical Research Institute, Durham, NC, USA; Department of Pediatrics, Duke University, Durham, NC, USA; Duke Clinical Research Institute, Durham, NC, USA
 show all
Pages 643-652 | Published online: 10 Jan 2014

Citations (89)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (9)

Min Yi, Bin Zhuo & Freda Cooner. (2023) RESTART trial design: two-stage seamless transition design with operational considerations. Journal of Biopharmaceutical Statistics 33:6, pages 820-829.
Read now
Klaus Rose, Earl B. Ettienne, Jane M. Grant-Kels, Pasquale Striano, David Neubauer & Oishi Tanjinatus. (2022) Neurology’s vital role in preventing unnecessary and potentially harmful pediatric studies. Expert Review of Neurotherapeutics 22:3, pages 209-219.
Read now
Silke Gastine, Asia N. Rashed, Yingfen Hsia, Charlotte Jackson, Charlotte I. S. Barker, Shrey Mathur, Stephen Tomlin, Irja Lutsar, Julia Bielicki, Joseph F. Standing & Mike Sharland. (2019) GAPPS (Grading and Assessment of Pharmacokinetic-Pharmacodynamic Studies) a critical appraisal system for antimicrobial PKPD studies – development and application in pediatric antibiotic studies. Expert Review of Clinical Pharmacology 12:12, pages 1091-1098.
Read now
Asia N Rashed, Charlotte Jackson, Silke Gastine, Yingfen Hsia, Julia Bielicki, Joseph F Standing, Stephen Tomlin & Mike Sharland. (2019) Pediatric pharmacokinetics of the antibiotics in the access and watch groups of the 2019 WHO model list of essential medicines for children: a systematic review. Expert Review of Clinical Pharmacology 12:12, pages 1099-1106.
Read now
Adam S. Himebauch, Todd J. Kilbaugh & Athena F. Zuppa. (2016) Pharmacotherapy during pediatric extracorporeal membrane oxygenation: a review. Expert Opinion on Drug Metabolism & Toxicology 12:10, pages 1133-1142.
Read now
Janko Samardzic, Mark A Turner, Ralph Bax & Karel Allegaert. (2015) Neonatal medicines research: challenges and opportunities. Expert Opinion on Drug Metabolism & Toxicology 11:7, pages 1041-1052.
Read now
Karel Allegaert. (2014) Tailored tools to improve pharmacotherapy in infants. Expert Opinion on Drug Metabolism & Toxicology 10:8, pages 1069-1078.
Read now
Martyn Gostelow, Daniel Gonzalez, P Brian Smith & Michael Cohen-Wolkowiez. (2014) Pharmacokinetics and safety of recently approved drugs used to treat methicillin-resistant Staphylococcus aureus infections in infants, children and adults. Expert Review of Clinical Pharmacology 7:3, pages 327-340.
Read now
Adam S Himebauch & Athena Zuppa. (2014) Methods for pharmacokinetic analysis in young children. Expert Opinion on Drug Metabolism & Toxicology 10:4, pages 497-509.
Read now

Articles from other publishers (80)

Hlayiseka Mathevula, Natalie Schellack, Samuel Orubu, Brian Godman & Moliehi Matlala. (2023) Off-Label and Unlicenced Medicine Use among Hospitalised Children in South Africa: Practice and Policy Implications. Pharmacy 11:6, pages 174.
Crossref
Elizabeth J. Thompson, Henry P. Foote, Kevin D. Hill & Christoph P. Hornik. (2023) A point-of-care pharmacokinetic/pharmacodynamic trial in critically ill children: Study design and feasibility. Contemporary Clinical Trials Communications 35, pages 101182.
Crossref
Jamil M. Kazma, John Van Den Anker & Homa K. Ahmadzia. (2022) Pharmacoethics and pregnancy: Overcoming the therapeutic orphan stigma. British Journal of Clinical Pharmacology 89:2, pages 483-490.
Crossref
Sonya Tang Girdwood, Kathryn Pavia, Kelli Paice, H. Rhodes Hambrick, Jennifer Kaplan & Alexander A. Vinks. (2022) β-lactam precision dosing in critically ill children: Current state and knowledge gaps. Frontiers in Pharmacology 13.
Crossref
Rachel G. Greenberg, Susan McCune, Sabah Attar, Collin Hovinga, Breanne Stewart & Thierry Lacaze-Masmonteil. (2022) Pediatric Clinical Research Networks: Role in Accelerating Development of Therapeutics in Children. Therapeutic Innovation & Regulatory Science 56:6, pages 934-947.
Crossref
Minjeong Nam, Mina Hur, Hanah Kim, Gun-Hyuk Lee, Mikyoung Park, Han-Sung Kwon, Han-Sung Hwang & In-Sook Sohn. (2022) Distribution of Presepsin, Krebs von den Lungen 6, and Surfactant Protein A in Umbilical Cord Blood. Diagnostics 12:9, pages 2213.
Crossref
Jianwen Xu, Rongfang Lin, Yong Chen, Xiang You, Pinfang Huang & Cuihong Lin. (2021) Physiologically Based Pharmacokinetic Modeling and Dose Adjustment of Teicoplanin in Pediatric Patients With Renal Impairment. The Journal of Clinical Pharmacology 62:5, pages 620-630.
Crossref
Stef SchouwenburgRobin F. J. van der KlipTim J. L. SmeetsNicole G. M. HunfeldRobert B. Flint, Matthijs de HoogHenrik EndemanBirgit C. P. KochEnno D. WildschutAlan Abdulla. (2022) Review of Scavenged Sampling for Sustainable Therapeutic Drug Monitoring: Do More With Less. Therapeutic Drug Monitoring 44:1, pages 215-223.
Crossref
Serife Kurul, Kinga Fiebig, Robert B. Flint, Irwin K. M. Reiss, Helmut Küster, Sinno H. P. Simons, Swantje Voller & H. Rob Taal. (2021) Knowledge gaps in late-onset neonatal sepsis in preterm neonates: a roadmap for future research. Pediatric Research 91:2, pages 368-379.
Crossref
Wesley Jackson, Daniel Gonzalez, P. Brian Smith, Namasivayam Ambalavanan, Andrew M. Atz, Gregory M. Sokol, Chi D. Hornik, Dan Stewart, Gratias Mundakel, Brenda B. Poindexter, Shawn K. Ahlfeld, Mary Mills, Michael Cohen-Wolkowiez, Karen Martz, Christoph P. Hornik & Matthew M. Laughon. (2021) Safety of sildenafil in extremely premature infants: a phase I trial. Journal of Perinatology 42:1, pages 31-36.
Crossref
Chie Emoto & Trevor N. Johnson. 2022. Pharmacology and Toxicology of Cytochrome P450 – 60th Anniversary. Pharmacology and Toxicology of Cytochrome P450 – 60th Anniversary 365 391 .
Nanae Tanemura, Tsuyoshi Sasaki, Junko Sato & Hisashi Urushihara. (2021) Study factors associated with the incompletion of clinical trials that include pediatric patients: a retrospective analysis of the European Clinical Trials Database and a lesson from the European region. Trials 22:1.
Crossref
Matthew W Bjergum, Erin F Barreto, Marc H Scheetz, Andrew D Rule & Paul J Jannetto. (2021) Stability and Validation of a High-Throughput LC-MS/MS Method for the Quantification of Cefepime, Meropenem, and Piperacillin and Tazobactam in Serum. The Journal of Applied Laboratory Medicine 6:5, pages 1202-1212.
Crossref
Abhishek G. Sathe, Richard C. Brundage, Vijay Ivaturi, James C. Cloyd, James M. Chamberlain, Jordan J. Elm, Robert Silbergleit, Jaideep Kapur & Lisa D. Coles. (2021) A pharmacokinetic simulation study to assess the performance of a sparse blood sampling approach to quantify early drug exposure. Clinical and Translational Science 14:4, pages 1444-1451.
Crossref
Sonya C. Tang Girdwood, Peter H. Tang, Mark E. Murphy, Andrea R. Chamberlain, Laura A. Benken, Rhonda L. Jones, Erin M. Stoneman, Jennifer M. Kaplan & Alexander A. Vinks. (2020) Demonstrating Feasibility of an Opportunistic Sampling Approach for Pharmacokinetic Studies of β‐Lactam Antibiotics in Critically Ill Children. The Journal of Clinical Pharmacology 61:4, pages 565-573.
Crossref
Anil R. Maharaj, Huali Wu, Kanecia O. Zimmerman, Julie Autmizguine, Rohit Kalra, Amira Al‐Uzri, Catherine M.T. Sherwin, Stuart L. Goldstein, Kevin Watt, Jinson Erinjeri, Elizabeth H. Payne, Michael Cohen‐Wolkowiez & Christoph P. Hornik. (2020) Population pharmacokinetics of olanzapine in children. British Journal of Clinical Pharmacology 87:2, pages 542-554.
Crossref
Sonya Tang Girdwood, Jennifer Kaplan & Alexander A Vinks. (2020) Methodologic Progress Note: Opportunistic Sampling for Pharmacology Studies in Hospitalized Children. Journal of Hospital Medicine 16:1, pages 35-37.
Crossref
Chie EMOTO, Kosuke DOKI, Yuki MATSUMOTO, Shinichi KIJIMA, Mikiko NAKAMURA & Tsuyoshi FUKUDA. (2020) Applications of PBPK Modeling and Simulations in The Clinical Pharmacology Field: Lessons from Several Case Studies臨床薬理分野での PBPK モデルの有効活用　―具体例を通して学ぶ―. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 51:6, pages 331-344.
Crossref
Chie EMOTO & Tsuyoshi FUKUDA. (2020) Applications of Pediatric PBPK Modeling: Current Status for Drug Development Processes and Use in Clinical Settings小児医薬品開発および臨床応用における生理学的薬物動態モデルの活用と現状. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 51:5, pages 267-276.
Crossref
David Hahn, Tsuyoshi Fukuda, Joshua C. Euteneuer, Tomoyuki Mizuno, Alexander A. Vinks, Senthilkumar Sadhasivam & Chie Emoto. (2020) Influence of MRP3 Genetics and Hepatic Expression Ontogeny for Morphine Disposition in Neonatal and Pediatric Patients. The Journal of Clinical Pharmacology 60:8, pages 992-998.
Crossref
Anil R. Maharaj, Huali Wu, Christoph P. Hornik, Antonio Arrieta, Laura James, Varsha Bhatt-Mehta, John Bradley, William J. Muller, Amira Al-Uzri, Kevin J. Downes & Michael Cohen-Wolkowiez. (2020) Use of normalized prediction distribution errors for assessing population physiologically-based pharmacokinetic model adequacy. Journal of Pharmacokinetics and Pharmacodynamics 47:3, pages 199-218.
Crossref
Angelica Intini, Donato Bonifazi & Giovanni Migliaccio. 2020. Drug Discovery and Development - New Advances. Drug Discovery and Development - New Advances.
Kanecia O. Zimmerman, Huali Wu, Matthew Laughon, Rachel G. Greenberg, Richard Walczak, Scott R. SchulmanP. Brian Smith, Christoph P. Hornik, Michael Cohen-Wolkowiez & Kevin M. Watt. (2019) Dexmedetomidine Pharmacokinetics and a New Dosing Paradigm in Infants Supported With Cardiopulmonary Bypass. Anesthesia & Analgesia 129:6, pages 1519-1528.
Crossref
Ryan J. BeechinorMichael Cohen-Wolkowiez, Theresa Jasion, Christoph P. Hornik, Jason E. LangRobert HernandezDaniel Gonzalez. (2019) A Dried Blood Spot Analysis for Solithromycin in Adolescents, Children, and Infants: A Short Communication. Therapeutic Drug Monitoring 41:6, pages 761-765.
Crossref
Elizabeth J. Thompson, Huali Wu, Anil Maharaj, Andrea N. Edginton, Stephen J. Balevic, Marjan Cobbaert, Anthony P. Cunningham, Christoph P. Hornik & Michael Cohen-Wolkowiez. (2019) Physiologically Based Pharmacokinetic Modeling for Trimethoprim and Sulfamethoxazole in Children. Clinical Pharmacokinetics 58:7, pages 887-898.
Crossref
Ronilda D'Cunha, John A. Widness, Xiaoyu Yan, Robert L. Schmidt, Peter Veng‐Pedersen & Guohua An. (2019) A Mechanism‐Based Population Pharmacokinetics Model of Erythropoietin in Premature Infants and Healthy Adults Following Multiple Intravenous Doses. The Journal of Clinical Pharmacology 59:6, pages 835-846.
Crossref
Florentia Kaguelidou, Geneviève Durrieu & Antonio Clavenna. (2019) Pharmacoepidemiological research for the development and evaluation of drugs in pediatrics. Therapies 74:2, pages 315-324.
Crossref
David Hahn, Chie Emoto, Joshua C. Euteneuer, Tomoyuki Mizuno, Alexander A. Vinks & Tsuyoshi Fukuda. (2018) Influence of OCT 1 Ontogeny and Genetic Variation on Morphine Disposition in Critically Ill Neonates: Lessons From PBPK Modeling and Clinical Study . Clinical Pharmacology & Therapeutics 105:3, pages 761-768.
Crossref
Klaus Rose & Philip D. Walson. (2019) Are Regulatory Age Limits in Pediatric Melanoma Justified?. Current Therapeutic Research 90, pages 113-118.
Crossref
Andrés Uribe-Restrepo, Alexandra Cossio, Mayur M. Desai, Diana Dávalos & María del Mar Castro. (2018) Interventions to treat cutaneous leishmaniasis in children: A systematic review. PLOS Neglected Tropical Diseases 12:12, pages e0006986.
Crossref
Wesley Jackson, Genevieve Taylor, David Selewski, P. Brian Smith, Sue Tolleson-Rinehart & Matthew M. Laughon. (2018) Association between furosemide in premature infants and sensorineural hearing loss and nephrocalcinosis: a systematic review. Maternal Health, Neonatology and Perinatology 4:1.
Crossref
Jennifer Le & John S. Bradley. (2018) Optimizing Antibiotic Drug Therapy in Pediatrics: Current State and Future Needs. The Journal of Clinical Pharmacology 58, pages S108-S122.
Crossref
Joan M. Korth-Bradley. (2018) The Path to Perfect Pediatric Posology - Drug Development in Pediatrics. The Journal of Clinical Pharmacology 58, pages S48-S57.
Crossref
Stephen J. Balevic & Michael Cohen-Wolkowiez. (2018) Innovative Study Designs Optimizing Clinical Pharmacology Research in Infants and Children. The Journal of Clinical Pharmacology 58, pages S58-S72.
Crossref
Bernard Fermini, Shawn T. Coyne & Kevin P. Coyne. (2018) Clinical Trials in a Dish: A Perspective on the Coming Revolution in Drug Development. SLAS Discovery 23:8, pages 765-776.
Crossref
Charlotte I S Barker, Joseph F Standing, Lauren E Kelly, Lauren Hanly Faught, Allison C Needham, Michael J Rieder, Saskia N de Wildt & Martin Offringa. (2018) Pharmacokinetic studies in children: recommendations for practice and research. Archives of Disease in Childhood, pages archdischild-2017-314506.
Crossref
Karin Kipper, Charlotte I. S. Barker, Joseph F. Standing, Mike Sharland & Atholl Johnston. (2018) Development of a Novel Multipenicillin Assay and Assessment of the Impact of Analyte Degradation: Lessons for Scavenged Sampling in Antimicrobial Pharmacokinetic Study Design. Antimicrobial Agents and Chemotherapy 62:1.
Crossref
Christoph P. Hornik, Nikolas J. Onufrak, P. Brian Smith, Michael Cohen-Wolkowiez, Matthew M. Laughon, Reese H. Clark & Daniel Gonzalez. (2017) Association between oral sildenafil dosing, predicted exposure, and systemic hypotension in hospitalised infants. Cardiology in the Young 28:1, pages 85-92.
Crossref
Belinda von Niederhäusern, Ramon Saccilotto, Sabine Schädelin, Victoria Ziesenitz, Pascal Benkert, Marie-Luise Decker, Anya Hammann, Julia Bielicki, Marc Pfister & Christiane Pauli-Magnus. (2017) Validity of mobile electronic data capture in clinical studies: a pilot study in a pediatric population. BMC Medical Research Methodology 17:1.
Crossref
Klaus Rose & Philip D. Walson. (2017) Do Paediatric Investigation Plans (PIPs) Advance Paediatric Healthcare?. Pediatric Drugs 19:6, pages 515-522.
Crossref
Christoph P. Hornik, Huali Wu, Andrea N. Edginton, Kevin Watt, Michael Cohen-Wolkowiez & Daniel Gonzalez. (2017) Development of a Pediatric Physiologically-Based Pharmacokinetic Model of Clindamycin Using Opportunistic Pharmacokinetic Data. Clinical Pharmacokinetics 56:11, pages 1343-1353.
Crossref
Mark A. Turner, Sabah Attar, Saskia N. de Wildt, Gilles Vassal, Laura Mangiarini & Carlo Giaquinto. (2017) Roles of Clinical Research Networks in Pediatric Drug Development. Clinical Therapeutics 39:10, pages 1939-1948.
Crossref
Stephen J. Balevic, Mara L. Becker, Michael Cohen-Wolkowiez & Laura E. Schanberg. (2017) Clinical Trial Design in Juvenile Idiopathic Arthritis. Pediatric Drugs 19:5, pages 379-389.
Crossref
Nazario D Rivera-Chaparro, Michael Cohen-Wolkowiez & Rachel G Greenberg. (2017) Dosing antibiotics in neonates: review of the pharmacokinetic data. Future Microbiology 12:11, pages 1001-1016.
Crossref
Gueorgui Dubrocq, Natella Rakhmanina & B. Ryan Phelps. (2017) Challenges and Opportunities in the Development of HIV Medications in Pediatric Patients. Pediatric Drugs 19:2, pages 91-98.
Crossref
Heather R. CrossAnthony HarrisRebekka M. AriasHenry F. “Chip” Chambers & Vance G. FowlerJrJr. (2017) Transforming Concepts Into Clinical Trials and Creating a Multisite Network: The Leadership and Operations Center of the Antibacterial Resistance Leadership Group. Clinical Infectious Diseases 64:suppl_1, pages S8-S12.
Crossref
Jou-Ku Chung, Boubou Hallberg, Ingrid Hansen-Pupp, Martin A. Graham, Gerald Fetterly, Jyoti Sharma, Adina Tocoian, Nerissa C. Kreher, Norman Barton, Ann Hellström & David Ley. (2016) Development and verification of a pharmacokinetic model to optimize physiologic replacement of rhIGF-1/rhIGFBP-3 in preterm infants. Pediatric Research 81:3, pages 504-510.
Crossref
Klaus Rose & Philip D. Walson. (2017) Do the European Medicines Agency Decisions Hurt Pediatric Melanoma Patients?. Clinical Therapeutics 39:2, pages 253-265.
Crossref
P. Brian Smith, Daniel K. BenjaminJrJr & Ann M. Reed. (2017) The Role of a Division of Quantitative Sciences Division in Enhancing Academic Productivity of a Department of Pediatrics. The Journal of Pediatrics 180, pages 4-5.
Crossref
Lisa Bomgaars, Stacey Berg & Ann R. Stark. 2017. Clinical and Translational Science. Clinical and Translational Science 573 586 .
Adam Frymoyer, Sonia L. Bonifacio, David R. Drover, Felice Su, Courtney J. Wustoff & Krisa P. Van Meurs. (2017) Decreased Morphine Clearance in Neonates With Hypoxic Ischemic Encephalopathy Receiving Hypothermia. The Journal of Clinical Pharmacology 57:1, pages 64-76.
Crossref
William Wei Lim Chin & Angelika Joos. (2016) Moving toward a paradigm shift in the regulatory requirements for pediatric medicines. European Journal of Pediatrics 175:12, pages 1881-1891.
Crossref
Christoph P. Hornik, Daniel K. BenjaminJrJr, P. Brian Smith, Michael J. Pencina, Adriana H. Tremoulet, Edmund V. Capparelli, Jessica E. Ericson, Reese H. Clark & Michael Cohen-Wolkowiez. (2016) Electronic Health Records and Pharmacokinetic Modeling to Assess the Relationship between Ampicillin Exposure and Seizure Risk in Neonates. The Journal of Pediatrics 178, pages 125-129.e1.
Crossref
Pathma D. Joseph, Jonathan C. Craig, Allison Tong & Patrina H.Y. Caldwell. (2016) Researchers’, Regulators’, and Sponsors’ Views on Pediatric Clinical Trials: A Multinational Study. Pediatrics 138:4.
Crossref
Sara L. Van Driest, Matthew D. Marshall, Brian Hachey, Cole Beck, Kim Crum, Jill Owen, Andrew H. Smith, Prince J. Kannankeril, Alison Woodworth, Richard M. Caprioli & Leena Choi. (2016) Pragmatic pharmacology: population pharmacokinetic analysis of fentanyl using remnant samples from children after cardiac surgery. British Journal of Clinical Pharmacology 81:6, pages 1165-1174.
Crossref
H. C. Pandya, H. Mulla, M. Hubbard, R. L. Cordell, P. S. Monks, S. Yakkundi, J. C. McElnay, A. J. Nunn & M. A. Turner. (2016) Essential medicines containing ethanol elevate blood acetaldehyde concentrations in neonates. European Journal of Pediatrics 175:6, pages 841-847.
Crossref
Amanda England, Kelly Wade, P. Brian Smith, Katherine Berezny & Matthew Laughon. (2016) Optimizing operational efficiencies in early phase trials: The Pediatric Trials Network experience. Contemporary Clinical Trials 47, pages 376-382.
Crossref
Kevin D. Hill, Mario R. Sampson, Jennifer S. Li, Robert D. Tunks, Scott R. Schulman & Michael Cohen-Wolkowiez. (2015) Pharmacokinetics of intravenous sildenafil in children with palliated single ventricle heart defects: effect of elevated hepatic pressures. Cardiology in the Young 26:2, pages 354-362.
Crossref
Jeremiah D. Momper, John Bradley & Brookie M. Best. 2016. Fundamentals of Pediatric Drug Dosing. Fundamentals of Pediatric Drug Dosing 83 92 .
Dionna Green & Valerie Amspacher. 2016. Fundamentals of Pediatric Drug Dosing. Fundamentals of Pediatric Drug Dosing 45 63 .
April V. P. Clyburne-Sherin, Pravheen Thurairajah, Mufiza Z. Kapadia, Margaret Sampson, Winnie W. Y. Chan & Martin Offringa. (2015) Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews. Trials 16:1.
Crossref
Kanecia Zimmerman, Daniel Gonzalez, Geeta K. Swamy & Michael Cohen-Wolkowiez. (2015) Pharmacologic studies in vulnerable populations: Using the pediatric experience. Seminars in Perinatology 39:7, pages 532-536.
Crossref
Tanay S. Samant, Naveen Mangal, Viera Lukacova & Stephan Schmidt. (2015) Quantitative clinical pharmacology for size and age scaling in pediatric drug development: A systematic review. The Journal of Clinical Pharmacology 55:11, pages 1207-1217.
Crossref
Abraham J. Valkenburg, Tom G. de Leeuw, Monique van Dijk & Dick Tibboel. (2015) Pain in Intellectually Disabled Children: Towards Evidence-Based Pharmacotherapy?. Pediatric Drugs 17:5, pages 339-348.
Crossref
Jian Wang, Andrea N. Edginton, Debbie Avant & Gilbert J. Burckart. (2015) Predicting neonatal pharmacokinetics from prior data using population pharmacokinetic modeling. The Journal of Clinical Pharmacology 55:10, pages 1175-1183.
Crossref
A. R. Kreeftmeijer-Vegter, T. P. C. Dorlo, M. P. Gruppen, A. de Boer & P. J. de Vries. (2015) Population pharmacokinetics of levamisole in children with steroid-sensitive nephrotic syndrome. British Journal of Clinical Pharmacology 80:2, pages 242-252.
Crossref
Daniel Gonzalez, Chiara Melloni, Brenda B Poindexter, Ram Yogev, Andrew M Atz, Janice E Sullivan, Susan R Mendley, Paula Delmore, Amy Delinsky, Kanecia Zimmerman, Andrew Lewandowski, Barrie Harper, Kenneth C Lewis, Daniel K BenjaminJrJr & Michael Cohen-Wolkowiez. (2015) Simultaneous determination of trimethoprim and sulfamethoxazole in dried plasma and urine spots. Bioanalysis 7:9, pages 1137-1149.
Crossref
Daniel Gonzalez, Kim A. Boggess & Michael Cohen-Wolkowiez. (2015) Lessons Learned in Pediatric Clinical Research to Evaluate Safe and Effective Use of Drugs in Pregnancy. Obstetrics & Gynecology 125:4, pages 953-958.
Crossref
Mark A. Turner. (2015) Clinical trials of medicines in neonates: the influence of ethical and practical issues on design and conduct. British Journal of Clinical Pharmacology 79:3, pages 370-378.
Crossref
Pathma D. Joseph, Jonathan C. Craig & Patrina H.Y. Caldwell. (2015) Clinical trials in children. British Journal of Clinical Pharmacology 79:3, pages 357-369.
Crossref
Mina Nikanjam, Clinton F. Stewart, Chris H. Takimoto, Timothy W. Synold, Orren Beaty, Maryam Fouladi & Edmund V. Capparelli. (2015) Population pharmacokinetic analysis of oxaliplatin in adults and children identifies important covariates for dosing. Cancer Chemotherapy and Pharmacology 75:3, pages 495-503.
Crossref
Lawrence C. Ku & P. Brian Smith. (2014) Dosing in neonates: special considerations in physiology and trial design. Pediatric Research 77:1, pages 2-9.
Crossref
J. G. Coen van Hasselt, Natasha K. A. van Eijkelenburg, Jos H. Beijnen, Jan H.M. Schellens & Alwin D. R. Huitema. (2014) Design of a drug-drug interaction study of vincristine with azole antifungals in pediatric cancer patients using clinical trial simulation. Pediatric Blood & Cancer 61:12, pages 2223-2229.
Crossref
D Gonzalez, C Melloni, R Yogev, B B Poindexter, S R Mendley, P Delmore, J E Sullivan, J Autmizguine, A Lewandowski, B Harper, K M Watt, K C Lewis, E V Capparelli, D K Benjamin & M Cohen-Wolkowiez. (2014) Use of Opportunistic Clinical Data and a Population Pharmacokinetic Model to Support Dosing of Clindamycin for Premature Infants to Adolescents. Clinical Pharmacology & Therapeutics 96:4, pages 429-437.
Crossref
K S Beam, S Aliaga, S K Ahlfeld, M Cohen-Wolkowiez, P B Smith & M M Laughon. (2014) A systematic review of randomized controlled trials for the prevention of bronchopulmonary dysplasia in infants. Journal of Perinatology 34:9, pages 705-710.
Crossref
M.A. Turner, M. Catapano, S. Hirschfeld & C. Giaquinto. (2014) Paediatric drug development: The impact of evolving regulations. Advanced Drug Delivery Reviews 73, pages 2-13.
Crossref
Jeremiah D. Momper, Gilbert J. Burckart & Pravin Jadhav. 2013. Pediatric Drug Development. Pediatric Drug Development 306 315 .
Karel Allegaert, Jean Paul Langhendries & John N. van den Anker. (2012) Educational paper: Do we need neonatal clinical pharmacologists?. European Journal of Pediatrics 172:4, pages 429-435.
Crossref
Prasarn Manitpisitkul, Kevin Shalayda, Mike Todd, Shean S. Wang, Seth Ness & Lisa Ford. (2012) Pharmacokinetics and safety of adjunctive topiramate in infants (1–24 months) with refractory partial‐onset seizures: A randomized, multicenter, open‐label phase 1 study. Epilepsia 54:1, pages 156-164.
Crossref
Karel Allegaert. (2012) Clinical pharmacological studies in children: From exploratory towards confirmation driven methodology. World Journal of Clinical Pediatrics 1:2, pages 3.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.